Theratechnologies Inc
NASDAQ:THTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Theratechnologies Inc
NASDAQ:THTX
|
CA |
|
Exor NV
F:EYX
|
NL |
|
Papa John's International Inc
NASDAQ:PZZA
|
US |
|
A
|
AstraZeneca PLC
BMV:AZNN
|
UK |
|
Microsoft Corp
NASDAQ:MSFT
|
US |
|
I
|
Interpublic Group of Companies Inc
XBER:IPG
|
US |
|
Parker-Hannifin Corp
NYSE:PH
|
US |
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
US |
|
R
|
Renault SA
F:RNL1
|
FR |
|
C
|
CAP SA
SGO:CAP
|
CL |
|
Koninklijke Ahold Delhaize NV
OTC:ADRNY
|
NL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is THTX's stock price target?
Not Available
THTX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Theratechnologies Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Theratechnologies Inc?
Projected CAGR
37%
The compound annual growth rate for Operating Income over the next 3 years is 37%.